Company Overview and News

 
Market Live: Midcap corrects in line with frontliners, Sensex dips over 150 pts; Nifty Bank in the green

2018-05-04 moneycontrol
Market Update: The market was reeling under selling pressure, with the Sensex falling more than 150 points but the Nifty Bank traded in the green.

 
Market Live: Sensex falls over 150 pts; all sectoral indices in the red barring Realty

2018-05-04 moneycontrol
Market Update: The market extended losses in late morning deals, with the Sensex falling more than 150 points on global weakness amid US-China trade talks.

 
Market Live: Nifty extends losses, Sensex breaks 35,000; RIL, HDFC, Infosys, ITC drag

2018-05-04 moneycontrol
Services PMI: India’s service sector continued to improve at the start of the quarter, with business activity rising at a faster pace, supported by new order growth. Reflecting improvements in demand conditions, job creation accelerated to the sharpest since March 2011. Inflationary price pressures continued to ease further, with input and output charge inflation registering below their respective historical averages, Nikkei IHS Markit said.

 
Market Live: Sensex, Nifty open lower on global weakness; Bharti Airtel jumps

2018-05-04 moneycontrol
Rupee Update: The rupee edged 2 paise lower to 62.66 against the US dollar after opening one paisa higher after the greenback weakened overseas ahead of monthly US jobs report and China-US trade meet outcome.

 
HFCL rises 3% on order win from BSNL; Q4 PAT jumps 86%

2018-05-04 moneycontrol
Share price of Himachal Futuristic Communication (HFCL) rose 3 percent in the early trade on Friday on the back of order win from BSNL and strong fourth quarter numbers.

 
Vanu India-HFCL bag Rs 579-cr project from BSNL in northeast region

2018-05-03 moneycontrol
Telecom gear firm Himachal Futuristic Communications Limited (HFCL) and Vanu India have jointly bagged a telecom network rollout project worth Rs 579 crore in the northeast region from state-run firm BSNL.

 
Himachal Futuristic Communications Limited - Press Release

2018-05-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Himachal Futuristic Communications Limited - Dividend

2018-05-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Himachal Futuristic Communications Limited - Financial Result Updates

2018-05-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Himachal Futuristic Communications Limited - Outcome of Board Meeting

2018-05-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Himachal Futuristic Communications Limited - Statement of deviation(s) or variation(s) under Reg. 32

2018-05-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Himachal Futuristic Communications Limited - Trading Window

2018-04-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Closing Bell: Nifty manages to hold 10,400, Sensex ends higher for 5th day

2018-04-11 moneycontrol
3:30 pm Market Closing: Benchmark indices closed higher for fifth consecutive session on Wednesday. The 30-share BSE Sensex was up 60.19 points at 33,940.44 and the 50-share NSE Nifty rose 14.90 points to 10,417.20.

Related Articles

ACIA: Acacia Communications Analysis and Research Report

just now - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...